Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats

被引:37
|
作者
Boesen, Erika I. [1 ]
Williams, Douglas L. [1 ]
Pollock, Jennifer S. [1 ]
Pollock, David M. [1 ]
机构
[1] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA
基金
美国国家卫生研究院;
关键词
hypertension; kidney; macrophage; mineralocorticoid; T-lymphocyte; IMMUNE CELL INFILTRATION; ANGIOTENSIN-II; SENSITIVE HYPERTENSION; BLOOD-PRESSURE; RENAL DAMAGE; MINERALOCORTICOID RECEPTORS; ARTERIAL-PRESSURE; OXIDATIVE STRESS; T-CELL; KIDNEY;
D O I
10.1111/j.1440-1681.2010.05428.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P>1. The interplay between the immune and renin-angiotensin systems is emerging as a crucial factor in the development and progression of hypertension. The aim of the present study was to determine the involvement of immune cells in the hypertension and renal injury produced by a non-angiotensin II-dependent form of hypertension, namely deoxycorticosterone acetate (DOCA)-salt-induced hypertension, in rats. 2. Male Sprague-Dawley rats underwent uninephrectomy and received either a sustained-release pellet of DOCA s.c. and 0.9% NaCl (saline) to drink for 21 days or a placebo pellet and water to drink for 21 days. Additional groups of DOCA-salt- and placebo-treated rats were treated concurrently with the immune suppressant mycophenolate mofetil (MMF; 30 mg/kg per day). Rats were placed in metabolic cages for 24 h urine collection prior to and at weekly intervals during the 21 day experimental period. 3. Mycophenolate mofetil significantly attenuated the development of hypertension in DOCA-salt rats compared with untreated DOCA-salt hypertensive rats (mean arterial pressure by telemetry on Day 18 146 +/- 7 vs 180 +/- 3 mmHg, respectively; P < 0.001), as well as proteinuria (87 +/- 27 vs 305 +/- 63 mg/day, respectively, on Day 21) and albuminuria (51 +/- 15 vs 247 +/- 73 mg/day, respectively, on Day 21). Creatinine clearance was better preserved in MMF-treated DOCA-salt rats compared with untreated DOCA-salt rats (0.74 +/- 0.07 vs 0.49 +/- 0.09 mL/min, respectively; P < 0.05), but was still significantly reduced compared with that in the placebo group (1.15 +/- 0.12 mL/min; P < 0.05). Finally, MMF treatment significantly attenuated the DOCA-salt-induced rise in renal cortical T-lymphocyte and macrophage infiltration (P < 0.05). 4. These data indicate that immune cells play a deleterious role in both the hypertension and renal injury associated with DOCA-salt hypertension.
引用
收藏
页码:1016 / 1022
页数:7
相关论文
共 50 条
  • [11] Bioactive Peptides from Ruditapes philippinarum Attenuate Hypertension and Cardiorenal Damage in Deoxycorticosterone Acetate-Salt Hypertensive Rats
    Sun, Zonghui
    Wang, Weixia
    Liu, Jinli
    Zou, Shengcan
    Yin, Dongli
    Lyu, Chenghan
    Yu, Jia
    Wei, Yuxi
    Gramza-Michalowska, Anna
    Kolanowski, Wojciech
    MOLECULES, 2023, 28 (22):
  • [12] A proteasome inhibitor prevents vascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats
    Takaoka, M
    Ohkita, M
    Itoh, M
    Kobayashi, Y
    Okamoto, H
    Matsumura, Y
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2001, 28 (5-6) : 466 - 468
  • [13] Relative contributions of mitochondria and NADPH oxidase to deoxycorticosterone acetate-salt hypertension in mice
    Zhang, Aihua
    Jia, Zhanjun
    Wang, Ningning
    Tidwell, Tyson J.
    Yang, Tianxin
    KIDNEY INTERNATIONAL, 2011, 80 (01) : 51 - 60
  • [14] VASCULAR KALLIKREIN IN DEOXYCORTICOSTERONE ACETATE SALT HYPERTENSIVE RATS
    NOLLY, H
    CARRETERO, OA
    LAMA, MC
    MIATELLO, R
    SCICLI, AG
    HYPERTENSION, 1994, 23 (01) : I185 - I188
  • [15] Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease
    Taylor, Erin B.
    Ryan, Michael J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (03):
  • [16] P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension
    Ji, Xu
    Naito, Yukiko
    Weng, Huachun
    Endo, Kosuke
    Ma, Xiao
    Iwai, Naoharu
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2012, 303 (08) : F1207 - F1215
  • [17] Deoxycorticosterone acetate-salt rats - Hypertension and sympathoexcitation driven by increased NaCl levels
    O'Donaughy, TL
    Brooks, VL
    HYPERTENSION, 2006, 47 (04) : 680 - 685
  • [18] Activation of Orexin 1 Receptors in the Paraventricular Nucleus Contributes to the Development of Deoxycorticosterone Acetate-Salt Hypertension Through Regulation of Vasopressin
    Bigalke, Jeremy A.
    Gao, Huanjia
    Chen, Qing-Hui
    Shan, Zhiying
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [19] Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone
    Moes, Arthur D.
    Severs, David
    Verdonk, Koen
    van der Lubbe, Nils
    Zietse, Robert
    Danser, A. H. J.
    Hoorn, Ewout J.
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [20] Antihypertensive and Renoprotective Effects of Dietary Flaxseed and its Mechanism of Action in Deoxycorticosterone Acetate-Salt Hypertensive Rats
    Watanabe, Yusuke
    Ohata, Kaori
    Fukanoki, Ayaka
    Fujimoto, Naoto
    Matsumoto, Maruri
    Nessa, Naseratun
    Toba, Hiroe
    Kobara, Miyuki
    Nakata, Tetsuo
    PHARMACOLOGY, 2020, 105 (1-2) : 54 - 62